Wells Fargo & Company Bio Restorative Therapies, Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BRTX
# of Institutions
14Shares Held
249KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA52.3KShares$83,7390.0% of portfolio
-
Stone X Group Inc.50.1KShares$80,1600.01% of portfolio
-
Wealth Alliance Mellville, NY40KShares$64,0000.01% of portfolio
-
Ubs Group Ag27.8KShares$44,5000.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.5KShares$32,7550.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $5.84M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...